Top

Published in:

01-01-2019 | Original Article

Relationship Between Serum B7-H3 Levels and Prognosis of Congenital Heart Disease in Children

Authors: Rufang Zhang, Jin Gong, Shouqing Wang, Li Shen, Yewei Xie, Xiaobing Li

Published in: Pediatric Cardiology | Issue 1/2019

Abstract

The aim of this study was to investigate the role of B7-H3 in prognosis of congenital heart disease (CHD) children patients. A total of 65 CHD patients within age 3–12 years who went to our hospital were included during August 2011 to December 2012. Demographic data including age, sex, weight, clinical basic information such as New York Heart Association (NYHA) class, pathological type were collected. Blood samples were collected and serum levels of B7-H3, C-reactive protein (CRP), N-Terminal Pro-Brain Natriuretic Peptide (NT-pro-BNP), and High-sensitivity Troponin T (hsTnT) were determined by enzyme-linked immunosorbent assay (ELISA). Characteristics including age, gender, weight, pathological type, NYHA class, and serum levels of hsTnT and CRP showed no significant difference between deceased and survival patients. However, serum levels of B7-H3 and NT-pro-BNP were significantly higher in deceased patients compared survival patients. Patients with high expressed B7-H3 had higher risks for total major cardiovascular events (MACE) occurrence compared with the lower group. Among the MACE events, significant difference was observed in rates of death, new onset of arrhythmias, and surgical, but not in NYHA class worsening and percutaneous intervention. Patients with higher levels if B7-H3 had significantly higher risk for mortality in the 5-year follow-up compared with the lower group, logic analysis was also conducted and results showed that B7-H3 might be an independent risk factor for 5-year mortality for CHD patients. B7-H3 was up-regulated in dead CHD patients, and serum levels of B7-H3 were related to long-term MACE and 5-year mortality of CHD patients.

Warburton D, Ronemus M, Kline J, Jobanputra V, Williams I, Anyane-Yeboa K, Chung W, Yu L, Wong N, Awad D (2014) The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet 133(1):11–27. https://doi.org/10.1007/s00439-013-1353-9 CrossRefPubMed

Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M (2013) Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. J Am Coll Cardiol 61(10):749–756. https://doi.org/10.1161/CIRCULATIONAHA.113.008396 CrossRef

Pan W, Wang Y, Lin L, Zhou G, Hua X, Mo L (2016) Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis. Paediatr Anaesth 26(3):239–248. https://doi.org/10.1111/pan.12820 CrossRefPubMed

Mussatto KA, Hoffmann RG, Hoffman GM, Tweddell JS, Bear L, Cao Y, Brosig C (2014) Risk and prevalence of developmental delay in young children with congenital heart disease. Pediatrics 133(3):e570. https://doi.org/10.1542/peds.2013-2309 CrossRefPubMedPubMedCentral

Mussatto KA, Hoffmann R, Hoffman G, Tweddell JS, Bear L, Cao Y, Tanem J, Brosig C (2015) Risk factors for abnormal developmental trajectories in young children with congenital heart disease. Circulation 132(8):755. https://doi.org/10.1161/CIRCULATIONAHA CrossRefPubMedPubMedCentral

Glatz AC, Purrington KS, Klinger A, King AR, Hellinger J, Zhu X, Gruber SB, Gruber PJ (2014) Cumulative exposure to medical radiation for children requiring surgery for congenital heart disease. J Pediatr 164(4):789–794. https://doi.org/10.1016/j.jpeds CrossRefPubMed

Zomer AC, Verheugt CL, Vaartjes I, Uiterwaal CS, Langemeijer MM, Koolbergen DR, Hazekamp MG, van Melle JP, Konings TC, Bellersen L (2011) Surgery in adults with congenital heart disease. Circulation 124(20):2195. https://doi.org/10.1161/CIRCULATIONAHA CrossRefPubMed

Ohuchi H, Diller GP (2014) Biomarkers in adult congenital heart disease heart failure. Heart Fail Clin 10(1):43–56CrossRefPubMed

Makimura M, Koga H (2014) N-terminal pro-brain natriuretic peptide as a useful predictor of early surgery in neonates with congenital heart diseases: a prospective observational study. Pediatr Cardiol 35(1):77–81. https://doi.org/10.1007/s00246-013-0744-y CrossRefPubMed

10.

Eindhoven JA, Roos-Hesselink JW, Bosch AEVD, Kardys I, Cheng JM, Veenis JF, Cuypers JAAE, Witsenburg M, Schaik RHNV, Boersma E (2015) High-sensitive troponin-T in adult congenital heart disease. Int J Cardiol 184(1):405–411. https://doi.org/10.1016/j.ijcard.2015.02.027 CrossRefPubMed

11.

Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, Maisel AS (2012) Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol 59(12):1101–1109. https://doi.org/10.1016/j.jacc.2011.11.046 CrossRefPubMedPubMedCentral

12.

Chen C, Shen Y, Qu QX, Chen XQ, Zhang XG, Huang JA (2013) Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp Cell Res 319(1):96–102. https://doi.org/10.1016/j.yexcr.2012.09.006 CrossRefPubMed

13.

Boland JM, Kwon ED, Harrington SM, Wampfler JA, Tang H, Yang P, Aubry MC (2013) Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung. Clin Lung Cancer 14(2):157–163. https://doi.org/10.1016/j.cllc.2012.05.006 CrossRefPubMed

14.

Yan L, Yuan Q, Jie H, Yi PL, Jian P, Xing F, Xue GZ, Jiang HW, Jian W (2016) Assessment of plasma B7-H3 levels in pediatric patients with different degrees of surgical stress. BMC Pediatr 16(1):110. https://doi.org/10.1186/s12887-016-0655-1 CrossRef

15.

Lin EY, Cohen HW, Bhatt AB, Stefanescu A, Dudzinski D, Defaria YD, Johnson J, Lui GK (2015) Predicting outcomes using the heart failure survival score in adults with moderate or complex congenital heart disease. Congenit Heart Dis 10(5):387–395. https://doi.org/10.1111/chd.12229 CrossRefPubMed

16.

Van Der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ (2011) The changing epidemiology of congenital heart disease. Nat Rev Cardiol 8(1):50–60. https://doi.org/10.1038/nrcardio.2010.166 CrossRefPubMed

17.

Zomer AC, Vaartjes I, Et VDV, de Jong HM, Konings TC, Wagenaar LJ, Heesen WF, Eerens F, Baur LH, Grobbee DE (2013) Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol 168(3):2487–2493. https://doi.org/10.1016/j.ijcard.2013.03.003 CrossRefPubMed

18.

Nir A, Luchner A, Rein AJ (2012) The natriuretic peptides as biomarkers for adults with congenital heart disease. Biomark Med 6(6):827–837. https://doi.org/10.2217/bmm.12.73 CrossRefPubMed

19.

Blok IM, van Riel AC, Schuuring MJ, de Bruin-Bon RH, van Dijk AP, Hoendermis ES, Zwinderman AH, Mulder BJ, Bouma BJ (2016) The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease. Int J Cardiol 209:242–247. https://doi.org/10.1016/j.ijcard.2016.02.003 CrossRefPubMed

20.

Frogoudaki A, Andreou C, Parissis J, Maniotis C, Nikolaou M, Rizos I, Filippatos G, Lekakis J (2014) Clinical and prognostic implications of plasma NGAL and NT-proBNP in adult patients with congenital heart disease. Int J Cardiol 177(3):1026–1030. https://doi.org/10.1016/j.ijcard.2014.09.134 CrossRefPubMed

21.

Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Dijk AP, de Bruin-Bon RH, Zwinderman AH, Mulder BJ, Bouma BJ (2015) New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study. Int J Cardiol 181:270–276. https://doi.org/10.1016/j.ijcard.2014.11.222 CrossRefPubMed

22.

Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Straalen JP, Boekholdt SM, Tijssen JG, Mulder BJ, Bouma BJ (2013) High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. Congenit Heart Dis 8(6):520–526. https://doi.org/10.1111/chd.12022 CrossRefPubMed

23.

Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S (2011) B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 102(5):1019–1024. https://doi.org/10.1111/j.1349-7006.2011.01877.x CrossRefPubMed

24.

Liu C, Liu J, Wang J, Liu Y, Zhang F, Lin W, Gao A, Sun M, Wang Y, Sun Y (2013) B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Mol Med Rep 7(1):134. https://doi.org/10.3892/mmr.2012.1158 CrossRefPubMed

Title: Relationship Between Serum B7-H3 Levels and Prognosis of Congenital Heart Disease in Children
Authors: Rufang Zhang
Jin Gong
Shouqing Wang
Li Shen
Yewei Xie
Xiaobing Li
Publication date: 01-01-2019
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 1/2019
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-018-1975-8

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Relationship Between Serum B7-H3 Levels and Prognosis of Congenital Heart Disease in Children

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Determinants of Exercise Performance in Children and Adolescents with Repaired Tetralogy of Fallot Using Stress Echocardiography

Short-Term and Mid-Term Results of Minimally Invasive Occlusion of Ventricular Septal Defects via a Subaxillary Approach in a Single Center

Eisenmenger Syndrome in Adults: Treatment Pattern and Prognostic Factors in the Advanced Pulmonary Vasodilator Era

Accuracy of a New Echocardiographic Index to Predict Need for Trans-annular Patch in Tetralogy of Fallot

Upcoming Events in Pediatric Cardiology

Arterial Structure and Function Following Viral Myocarditis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page